- Development of Natural Peptide Antimicrobial Agent against MRSA
Breast cancer is one of the most common and deadly forms of cancer, affecting millions of people worldwide. While significant progress has been made in the development of various treatment options, including chemotherapy, radiation therapy, and targeted therapies, there and less toxic alternatives. Natural anticancer is still a pressing need for more effective peptides have emerged as a promising approach to address this challenge.
In this study, we aim to develop a novel anticancer peptide (ACP) from a natural source to selectively induce programmed cell death in the cancer cells. Natural ACPs can trigger the activation of key apoptotic signaling pathways, leading to the elimination of cancer cells while minimizing the impact on healthy cells. This aims to provide a more targeted and less toxic treatment option compared to conventional chemotherapies.
Currently run by: Mais Al Majali (M.Sc. student)